30
Participants
Start Date
October 7, 2021
Primary Completion Date
October 17, 2023
Study Completion Date
October 17, 2023
PF-07260437
B7-H4 x CD3 bi-specific mAb
B7-H4 IHC
B7-H4 expression
Montefiore Einstein Center for Cancer Care, The Bronx
Moffitt Cancer Center at McKinley Campus, Tampa
Moffitt Cancer Center, Tampa
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
The University of Chicago Medicine Center of Advanced Care Orland Park, Orland Park
University of Chicago Medical Center, Chicago
NEXT Oncology, San Antonio
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Swedish Cancer Institute Edmonds Campus, Edmonds
Swedish Cancer Institute, Seattle
Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center - Mountlake, Seattle
Pan American Center for Oncology Trials, LLC, Rio Piedras
Pan American Center for Oncology Trials- Hospital Oncologico, Rio Piedras
Pan American Center for Oncology Trials, Rio Piedras
Lead Sponsor
Pfizer
INDUSTRY